Gsk (GSK) Income from Non-Controlling Interests (2009 - 2026)
Gsk's Income from Non-Controlling Interests came in at $295.38 million for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 8, 2026, Gsk reported Income from Non-Controlling Interests of $1.35 billion; for the year ended Dec 31, 2025, it was $755.51 million, up 57.2% from the prior year.
- Income from Non-Controlling Interests carries a five-year compound annual growth rate of 15.1% (years ended Dec 2020 to Dec 2025).
- Going back by year, Income from Non-Controlling Interests was $480.63 million in the year ended Dec 31, 2024 (+1.7%), $472.65 million in the year ended Dec 31, 2023 (-17.0%), $569.3 million in the year ended Dec 31, 2022 (+106.9%) and $275.18 million in the year ended Dec 31, 2021 (-26.4%).
- The five-year range for quarterly Income from Non-Controlling Interests is -$8.09 million (the quarter ended Dec 31, 2021) to $762.19 million (the quarter ended Dec 31, 2025).
- Year-over-year, Income from Non-Controlling Interests increased in five of the last seven quarters, with growth averaging 142.4%.
- The fastest year-over-year change in Income from Non-Controlling Interests over five years came in the quarter ended Dec 31, 2025 (growth of 582.6%), and the weakest in the quarter ended Sep 30, 2022 (a decline of 75.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | - |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | - |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 741.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 741.95 Mn |
| Mar 31, 2026 | 2.48 Bn |
| Dec 31, 2025 | 8.37 Bn |
| Sep 30, 2025 | 2.89 Bn |
| Jun 30, 2025 | 2.20 Bn |
| Mar 31, 2025 | 2.23 Bn |
| Dec 31, 2024 | 3.79 Bn |
| Sep 30, 2024 | 84.45 Mn |
| Jun 30, 2024 | 1.65 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 6.59 Bn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 2.18 Bn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 18.32 Bn |
| Sep 30, 2022 | 12.80 Bn |
| Jun 30, 2022 | 1.23 Bn |
| Mar 31, 2022 | 2.91 Bn |
| Dec 31, 2021 | 6.87 Bn |
| Sep 30, 2021 | 1.89 Bn |
API Access
Gsk Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();